What was verified about cost for Pallas Health NAD+ injection?

The canonical catalog records $199 a month after a first month at $89 for NAD+ injection, checked 22 August 2026. The amount should be read with any introduction, prepayment, or commitment shown in the same offer record. It is a dated published commercial fact, not a promise that every checkout configuration, future renewal, or product change will cost the same amount.

What does included mean here in the Pallas Health figure?

The canonical Pallas Health offer marks medication as included for NAD+ injection. That field does not automatically include labs, every consultation, supplies, faster shipping, dose-related price changes, or a future refill. Confirm those items and the complete charge in the selected checkout before treating the figure as all-inclusive.

Why keep the exact product name for Pallas Health NAD+ injection?

This record is limited to NAD+ injection in Subcutaneous injection format. It does not transfer price, regulatory status, evidence, convenience, dosing, pharmacy, or fulfillment claims to another NAD+ injection formulation or to a related product. Compare route and product identity before comparing the price because similar medication names can still describe materially different offers.

What can limit fulfillment for Pallas Health NAD+ injection?

The current provider record marks this vertical as all-states, but individual eligibility and fulfillment still require confirmation. The state record is only one access field. Pallas Health must also confirm clinician licensure, product eligibility, and pharmacy fulfillment for the specific NAD+ injection prescription. Completing an intake does not guarantee approval, dispensing, or a particular outcome.

How should I build a shortlist for Pallas Health NAD+ injection?

Use the canonical NAD+ injection program comparison. It reads current provider and price data from the registry and preserves the nad-injection treatment route. Compare Pallas Health only with offers that disclose the same price components, medication inclusion, commitment, and format; otherwise explain why the rows are not directly equivalent.

Provider treatment guide · checked 22 August 2026

Pallas Health NAD+ injection

Published by Telehealth LedgerSource checked 22 August 2026Editorial policy

Pallas Health lists NAD+ injection at $199 a month after a first month at $89. Medication is included in that catalog price. Readers choosing an injectable NAD route at Pallas Health who need the injection's own price basis and inclusions rather than blended NAD program information. The commercial terms were checked 22 August 2026; state access, clinician approval, dispensing details, and personal suitability remain separate questions.

Visit Pallas Health View the provider profile

Pallas Health NAD+ injection treatment illustration

$199a month after a first month at $89

Includedmedication in catalog price

Subcutaneous injectioncataloged format

22 August 2026commercial terms checked

All states listedstate-access record

The commercial question this page answers: Pallas Health NAD+ injection

Determine whether Pallas Health's injectable NAD listing is the route the reader intends to price, then distinguish its catalog facts from the provider's NAD nasal spray offer.

Readers choosing an injectable NAD route at Pallas Health who need the injection's own price basis and inclusions rather than blended NAD program information. This is a commercial fit statement, not a clinical suitability judgment. The catalog can verify a product, format, price basis, and source date, while a clinician must decide eligibility.

Start with continuing cost, not the headline: Pallas Health

Pallas Health's canonical offer lists NAD+ injection at $199 a month after a first month at $89. The number is computed from the same registry fields used by the treatment comparison, not copied into this draft as a fixed editorial amount. That connection matters because a future catalog correction can update the displayed commercial fact without leaving this guide on a stale, contradictory figure.

The canonical offer marks medication as included in the displayed price. It does not verify that labs, every consultation, supplies, expedited shipping, or future dose changes are included unless the source says so. Those items remain checkout questions. For Pallas Health NAD+ injection, read inclusion as one field in the offer record, not as proof that every service surrounding the prescription is free. The dated source establishes the advertised basis; it does not independently audit the final checkout, dispensing event, or quality of care.

Route and regulatory status: NAD+ injection

NAD+ injection is cataloged as a compounded product in Subcutaneous injection format. FDA states that compounded drugs are not FDA-approved and do not receive the same premarket review as approved drug products. Ask for the exact formulation and dispensing pharmacy before purchase. That status is central to this Pallas Health guide because a related medication name does not make branded, compounded, oral, nasal, and injectable products interchangeable.

Subcutaneous injection is the exact format attached to Pallas Health's offer, while the canonical owner describes this comparison unit as Compounded NAD+ injection. Route matters for product identification, fulfillment, source selection, and a fair price comparison. This draft does not supply dose instructions, route conversions, or a claim that another formulation would have the same evidence, safety profile, convenience, or outcome.

Do not infer nationwide access: NAD+ injection

The canonical provider record marks this nad program as available in all states as of its review date. Licensing, clinical eligibility, and fulfillment still need confirmation during intake. The NAD+ injection access check belongs near the price because a low published figure has little decision value when Pallas Health cannot serve the reader's state or the selected product cannot be fulfilled there.

For Pallas Health NAD+ injection, the consumer brand, administrative platform, clinical group, and dispensing pharmacy can be different entities. A provider page may describe a national service while licensure, product rules, and pharmacy coverage narrow actual fulfillment. Ask which clinician entity would review the intake and which licensed pharmacy would dispense this exact product in the reader's state before treating access as settled.

Roles, policies, and unresolved facts: Pallas Health

Lion MD via CareValidate is recorded in the Pallas Health dossier as medical group. Clinical service and named clinicians are disclosed on the clinical page. These entities can perform different jobs, so the consumer-facing brand should not automatically be described as the clinician or dispensing pharmacy for NAD+ injection.

Refund boundary: Clinician declines and unfulfilled orders receive full refunds; eligible pre-fill cancellation can incur fees, and shipped medication is not refundable. The dossier also preserves this boundary for Pallas Health's NAD+ injection decision: Brand-name cash prices can change and should be rechecked before purchase. Carry that dated limitation into checkout instead of assuming a catalog price settles operations, fulfillment, or eligibility.

Promotion, renewal, and prepayment: Pallas Health NAD+ injection

The catalog has both a continuing option at $199 a month after a first month at $89 and a prepaid option at $199 a month, paying $597 for 3 months up front. Those are different commitments. Compare the total charged today, the renewal path, and the cancellation deadline rather than treating the lowest monthly equivalent as month to month. This is why Telehealth Ledger keeps introductory, recurring, upfront, effective-monthly, and commitment fields separate for Pallas Health's NAD+ injection offer. A monthly equivalent can be useful, but only when the required payment and term remain visible beside it.

The Pallas Health source for this edge was checked on 22 August 2026. Before paying for NAD+ injection, compare the amount charged today with the amount charged later, the number of months purchased, the renewal date, the cancellation window, and the refund boundary after clinical or pharmacy processing. A current catalog price cannot safely answer those policy questions unless the cited provider evidence does.

A fair comparison frame: NAD+ injection

The linked NAD+ injection owner is the right place to rank Pallas Health beside other cataloged offers. Use the same fields for every row: continuing price, introductory period, required prepayment, medication inclusion, product type, delivery format, verification date, and state evidence. If two offers use different routes or one price excludes medication, a simple lowest-number verdict would not be a like-for-like conclusion.

From this Pallas Health guide, the comparison link resolves to the canonical NAD+ injection program owner, and the provider action uses the catalog's treatment-specific destination when one exists. Otherwise it uses the matching nad destination. That routing keeps the reader in the correct treatment lane and avoids sending a NAD+ injection decision to an unrelated offer.

What to confirm next: Pallas Health NAD+ injection

A place on the Pallas Health shortlist depends on whether the reader accepts NAD+ injection, the subcutaneous injection format, and the recorded NAD+ injection billing basis. A lower apparent number should not override product identity or required commitment.

Readers choosing an injectable NAD route at Pallas Health who need the injection's own price basis and inclusions rather than blended NAD program information. A sound decision keeps the source date visible and refuses to convert missing operational detail into a favorable assumption.

Common questions

Pallas Health NAD+ injection FAQ

What was verified about cost for Pallas Health NAD+ injection?: The canonical catalog records $199 a month after a first month at $89 for NAD+ injection, checked 22 August 2026. The amount should be read with any introduction, prepayment, or commitment shown in the same offer record. It is a dated published commercial fact, not a promise that every checkout configuration, future renewal, or product change will cost the same amount.
What does included mean here in the Pallas Health figure?: The canonical Pallas Health offer marks medication as included for NAD+ injection. That field does not automatically include labs, every consultation, supplies, faster shipping, dose-related price changes, or a future refill. Confirm those items and the complete charge in the selected checkout before treating the figure as all-inclusive.
Why keep the exact product name for Pallas Health NAD+ injection?: This record is limited to NAD+ injection in Subcutaneous injection format. It does not transfer price, regulatory status, evidence, convenience, dosing, pharmacy, or fulfillment claims to another NAD+ injection formulation or to a related product. Compare route and product identity before comparing the price because similar medication names can still describe materially different offers.
What can limit fulfillment for Pallas Health NAD+ injection?: The current provider record marks this vertical as all-states, but individual eligibility and fulfillment still require confirmation. The state record is only one access field. Pallas Health must also confirm clinician licensure, product eligibility, and pharmacy fulfillment for the specific NAD+ injection prescription. Completing an intake does not guarantee approval, dispensing, or a particular outcome.
How should I build a shortlist for Pallas Health NAD+ injection?: Use the canonical NAD+ injection program comparison. It reads current provider and price data from the registry and preserves the nad-injection treatment route. Compare Pallas Health only with offers that disclose the same price components, medication inclusion, commitment, and format; otherwise explain why the rows are not directly equivalent.

Sources and method

Telehealth Ledger checked provider pages, plan terms, and independent context on 22 August 2026. This page compares published commercial terms. It is not a rating, medical advice, or a guarantee that a clinician will prescribe treatment.